BioRestorative Therapies (BRTX) Institutional Ownership → They say it’s ‘unstoppable’ – How I made 43,509% (From Investing Daily) (Ad) Free BRTX Stock Alerts $1.25 +0.02 (+1.63%) (As of 04/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for BioRestorative Therapies (NASDAQ:BRTX)CurrentInstitutional OwnershipPercentage69.38%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$62.05KNumber ofInstitutional Sellers(last 12 months)0 Get BRTX Insider Trade Alerts Want to know when executives and insiders are buying or selling BioRestorative Therapies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Investing DailyThey say it’s ‘unstoppable’ – How I made 43,509% Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. BioRestorative Therapies Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/1/2023Lynwood Capital Management Inc.20,000$36K0.1%N/A0.428% 10/10/2023FNY Investment Advisers LLC14,665$26K0.0%N/A0.314% (Data available from 1/1/2016 forward) BRTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BRTX shares? During the previous two years, the following institutional investors and hedge funds held shares of BioRestorative Therapies shares: Lynwood Capital Management Inc. ($36K), FNY Investment Advisers LLC ($26K).Learn more on BRTX's institutional investors. What percentage of BioRestorative Therapies stock is owned by institutional investors? 69.38% of BioRestorative Therapies stock is owned by institutional investors. Learn more on BRTX's institutional investor holdings. Which institutional investors have been buying BioRestorative Therapies stock? The following institutional investors have purchased BioRestorative Therapies stock in the last 24 months: Lynwood Capital Management Inc. ($20K), and FNY Investment Advisers LLC ($14.67K). How much institutional buying is happening at BioRestorative Therapies? Institutional investors have bought a total of 34,665 shares in the last 24 months. This purchase volume represents approximately $62.05K in transactions. Related Companies: Ontrak Institutional Ownership Mangoceuticals Institutional Ownership NeuroMetrix Institutional Ownership Genetic Technologies Institutional Ownership Biofrontera Institutional Ownership Molecular Templates Institutional Ownership Cosmos Health Institutional Ownership Virios Therapeutics Institutional Ownership NuCana Institutional Ownership Vapotherm Institutional Ownership This page (NASDAQ:BRTX) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe World's First "$20 Trillion Drug?"Behind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioRestorative Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
